News
Sarepta Therapeutics’ Long-Term Potential Intact Despite Near-Term Stock Weakness (SRPT)
This article was written byFollowI've been writing for Seeking Alpha since 2017 with a focus on healthcare and technology investments.…
FHLC: Poised To Capture Strong Healthcare Demand And Growth
This article was written byFollowWilson Research seeks to provide investors with focused insights on predominantly exchange-traded funds, or ETFs, with…
Why Charles Schwab Is A Strong Buy Even With Market Uncertainty (NYSE:SCHW)
This article was written byFollowMotti Sapir is an economist and financial analyst with over 15 years of experience in financial…
Celsius: All Eyes On Growth (NASDAQ:CELH)
This article was written byFollowHello, my name is Cyril Thomas, and I am an experienced financial analyst with over four…
Gaotu Techedu: Strong Growth And Improved Profitability, Maintain ‘Buy’ (NYSE:GOTU)
This article was written byFollowI am the co-founder and portfolio manager for a multi-family office with a focus on U.S…
Archrock Stock: Emerging As A True Industry Leader (NYSE:AROC)
This article was written byFollowI am a Licensed Professional Engineer who works in the Nuclear Power industry. I use my…
Lloyds Banking Group Stock: How The Supreme Court Ruling May Affect The Stock (NYSE:LYG)
This article was written byFollowAt Investors' Edge, we specialise in identifying undervalued companies with strong fundamentals and great growth potential.…
Immersion Stock: Undervalued, With A Bevy Of Potential Catalysts On Tap (NASDAQ:IMMR)
This article was written byFollowI am a value investor focused on opportunities in undervalued micro-cap and small-cap stocks, with a…